Bill · S. 1702· Senate(119-S-1702)
Access to Prescription Digital Therapeutics Act of 2025
- Introduced
- 5/8/2025
- Last activity
- 5/8/2025 — Read twice and referred to the Committee on Finance.
- Sponsored by
- Shelley Capito
- Cosponsors
- - 2 - 2
- Introduced
- In Committee
What this bill would do
The Access to Prescription Digital Therapeutics Act of 2025 aims to amend the Social Security Act to include coverage for prescription digital therapeutics. This includes amending titles XVIII and XIX to ensure these technologies are covered under Medicare and Medicaid. The bill defines these therapeutics as software-based products or applications cleared or approved for treating specific medical conditions. For Medicare, the bill directs the Secretary to establish payment methodologies and product-specific codes. It also establishes reporting requirements for manufacturers regarding payment rates and user volume.
Yes· 3 of 6
Would people over 65 be better off under this?+6
The bill expands Medicare coverage for digital therapeutic products.
Would retired people be better off under this?+6
The bill enhances Medicare benefits by covering prescription digital therapeutics.
Does this make health care easier to get in general?+6
The bill increases access to medical conditions through the coverage of prescription digital therapeutics.
The opposite
No question was scored the opposite.
Who it would affect, and how
Potential Positive Impacts for People
-
Medicare Coverage for Digital Therapeutics: By amending section 1861(s)(2), the bill allows prescription digital therapeutics furnished on or after January 1, 2026, to be covered as a medical and other health service under Medicare (Section 2(b)).
-
Medicaid Coverage for Digital Therapeutics: The bill amends section 1905(a) to include prescription digital therapeutics in the list of covered services under the Medicaid program (Section 3).
-
Establishment of Payment Systems: The Secretary is required to create a payment methodology for manufacturers, which may include one-time or periodic payments, ensuring a structured system for these products (Section 2(c)(a)(1)).
Potential Negative Impacts for People
- Penalties for Manufacturers: Manufacturers that fail to report required information, or that misrepresent or omit information in their reports, may face civil money penalties of up to $10,000 per day (Section 2(c)(3)(A)).
Groups and Interests Ranking
Every group the model scored this bill for, from -10 to +10. Hover a score for the reason it gave.
- Demographic And Interest Groups
- Good For Retirees+6Good For Seniors+6Good For Low Income Households+5
- Healthcare
- Improves Healthcare Access+6Increases Medicaid Funding+5Increases Medicare Funding+5
- 6/16/2026
- 1 Cosponsor added.
- 12/10/2025
- 1 Cosponsor added.
- 7/15/2025
- 1 Cosponsor added.
- 5/8/2025
- Read twice and referred to the Committee on Finance.
- 1 Cosponsor added.
- Introduced in Senate
One bill Congress.gov lists as related to this one — companions in the other chamber, earlier versions, and bills this one absorbed or was folded into.
Marsha BlackburnRepublican · Tennessee
Cory BookerDemocrat · New Jersey
Ted BuddRepublican · North Carolina
Jeanne ShaheenDemocrat · New Hampshire